Tag: Clinical Trials

June 4, 2019

Yoga refers to a series of mind-body practices that originate in Hindu tradition. However, they are growing in popularity across the world as an alternative well-being practice. Statistic show that in 2015 in the United States alone, as many as […]

January 30, 2019

The Food and Drug Administration plans to exploit claims, clinical and patient-generated data—information not captured through traditional clinical trials—for post-marketing safety surveillance. “New streams of real-world data gathered from electronic health records, lab tests, wearable devices, insurance claims and even […]

November 13, 2018

At its annual R&D investor day, Novartis updated the world on its drug pipeline and research priorities. It was an impressive session befitting a company that spends $9 billion annually on R&D (about 18% of its top line revenues). Novartis […]

July 20, 2018

A drug currently in clinical trials for treating symptoms of Parkinson’s disease may someday have value for treating heart failure, according to results of early animal studies by Johns Hopkins Medicine researchers. The drug, a member of a class of […]

February 23, 2018

Results from early clinical trials investigating new treatments for chronic diseases may be drastically exaggerated, according to an analysis published this week. As the average human lifespan slowly expands, the number of people with chronic conditions is steadily rising. In […]

December 1, 2017

Molecular information firm Foundation Medicine has secured approval from the US Food and Drug Administration (FDA) for its comprehensive companion diagnostic test, FoundationOne CDx, for solid tumours. The genomic profiling (CGP) test is designed to identify people who could benefit […]

November 7, 2017

A popular drug commonly used to treat Alzheimer’s disease has shown promise in laboratory and clinical trials for treating patients with sickle cell disease (SCD). Researchers have found that the molecule memantine stabilizes the development, longevity and function of red […]

October 24, 2017

You might have heard that many new cancer medicines offer little benefit. This month, the BMJ published a review finding that for most cancer drugs approved by the European Medicines Agency between 2009 and 2013, there was neither published evidence […]

August 23, 2016

Earlier this month, a consortium of 282 clinical trials doctors, in an article in the New England Journal of Medicine, threw down the gauntlet against data sharing. Under the misleading title “Towards fairness in data sharing,” these scientists, who label […]

August 18, 2016

Mayo Clinic, along with other members of the Geroscience Network, has published six manuscripts that map strategies for taking new drugs that target processes underlying aging into clinical trials. Researchers believe that these agents hold promise for treating multiple age-related […]